StockWatch
·

Narayana Hrudayalaya Ltd Q4 FY26 Results

NHQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue1.0K7.8%13.6%
Total Income1.2K18.9%14.2%
Expenditure906.938.0%11.3%
PBT264.18166.2%25.2%
Net Profit202.13166.9%26.4%
OPM21.71%5.25pp2.58pp
NPM17.26%9.57pp1.66pp
EPS9.95166.8%26.3%
View full financials

Narayana Hrudayalaya FY26 Revenue Up 44% to ₹78,960 Mn

22 May 2026 · 22 May, 10:21 pm

Summary

Narayana Hrudayalaya Limited announced a strong financial performance for Q4 FY26 and the full fiscal year FY26. Consolidated operating revenue for Q4 FY26 surged by 75.8% year-on-year to ₹2,593.8 crore, contributing to an impressive FY26 consolidated revenue of ₹7,896.0 crore, a 44.0% increase from the previous year. Adjusted EBITDA for Q4 FY26 rose by 40.3% to ₹539.4 crore, with a 20.8% margin, while the full year adjusted PAT grew by 18.7% to ₹937.4 crore, achieving an 11.9% margin. The company highlighted robust growth across its India and international operations, particularly noting the significant contribution from its UK segment which became operational in November 2025.

Key Highlights

  1. 1

    Narayana Hrudayalaya Limited reported a significant consolidated operating revenue of ₹2,593.8 crore for Q4 FY26, marking a robust 75.8% year-on-year growth.

  2. 2

    For the full fiscal year FY26, consolidated operating revenue reached ₹7,896.0 crore, demonstrating a substantial 44.0% increase compared to the previous year.

  3. 3

    Adjusted EBITDA for Q4 FY26 grew by 40.3% year-on-year to ₹539.4 crore, maintaining a margin of 20.8%.

  4. 4

    The company achieved an adjusted PAT of ₹937.4 crore for FY26, an 18.7% increase year-on-year, with an adjusted PAT margin of 11.9%.

  5. 5

    India's operating revenue contributed ₹4,797.4 crore to FY26 results, showing a healthy 10.3% year-on-year growth.

  6. 6

    The UK segment, operational from November 6, 2025, contributed ₹1,299.2 crore to FY26 revenue, with Q4 FY26 UK revenue at ₹809.0 crore, up 65% quarter-on-quarter.

  7. 7

    The Group successfully performed over 750 robotic cardiac surgeries in FY26, including 160 TAVIs, showcasing strong clinical volumes and advanced procedural capabilities.

Management Comments

D

Dr. Emmanuel Rupert

Commenting on the performance, Dr. Emmanuel Rupert, Managing Director and Gro

Informational and educational content only. Not investment advice.